Products Categories
| CAS No.: | 149-29-1 |
|---|---|
| Name: | PATULIN |
| Molecular Structure: | |
|
|
|
| Formula: | C7H6 O4 |
| Molecular Weight: | 154.13 |
| Synonyms: | Patulin(6CI); 4-Hydroxy-4H-furo[3,2-c]pyran-2(6H)-one; Acetic acid,(2,4-dihydroxy-2H-pyran-3(6H)-ylidene)-, 3,4-lactone; Clairformin; Clavacin;Clavatin; Claviformin; DL-Patulin; Expansin; Expansin (antibiotic); Expansine;Mycoin; Mycoin C; Mycoin C3; NSC 32951; NSC 8120; Patuline; Penicidin; Terinin |
| EINECS: | 205-735-2 |
| Density: | 1.52 g/cm3 |
| Melting Point: | 108-111 °C |
| Boiling Point: | 513.7 °C at 760 mmHg |
| Flash Point: | 226.8 °C |
| Solubility: | Soluble in water |
| Appearance: | white Crystalline |
| Hazard Symbols: |
 T Xn
|
| Risk Codes: | 25-38-48/20/22-40-22 |
| Safety: | 45-36/37 |
| Transport Information: | UN 3462 6.1/PG 2 |
| PSA: | 55.76000 |
| LogP: | -0.29790 |
- 483366-12-7(2S,4R)-1-Boc-2-cyano-4-hydroxypyrrolidine
- 173606-50-3BOC-10-AMINODECANOIC ACID
- 361456-36-2METHYL (R)-(+)-ISOCYANATO-3-PHENYLPROPI&
- 5156-58-1N-(1-Benzyl-4-pipperidinyl)-N-phenylpropanamide HCl
- 81281-59-67-Benzylideneaminotheophylline
- 50288-62-5threo-Phenyl-2-piperidyl acetamide
- 82993-81-5D-threo-Ritalinic acid hydrochloride
- 47087-37-6Z-D-Glu-OMe
- 73441-42-6METHYL-5-CHLORO-2,2-DIMETHYLVALERATE
- 211914-50-0N-[[2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-(2-pyridinyl)-beta-alanine ethyl ester hydrochloride
- Total:33 Page 1 of 1 1
What can I do for you?
Get Best Price
Chemistry
Product Name: Clavacin (CAS NO.149-29-1)
Molecular Formula: C7H6O4
Molecular Weight: 154.12g/mol
Mol File: 149-29-1.mol
Einecs: 205-735-2
Appearance: White crystals or fine crystalline powder
Melting Point: 108-111 °C
Boiling point: 513.7 °C at 760 mmHg
Storage Temperature: −20°C
Flash Point: 226.8 °C
Density: 1.52 g/cm3
Water Solubility: Soluble in water
Surface Tension: 58 dyne/cm
Enthalpy of Vaporization: 90.37 kJ/mol
Vapour Pressure: 1.06E-12 mmHg at 25°C
XLogP3-AA: -1
H-Bond Donor: 1
H-Bond Acceptor: 4
Toxicity Data With Reference
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| chicken | LD50 | unreported | 170mg/kg (170mg/kg) | Reviews of Environmental Contamination and Toxicology. Vol. 113, Pg. 47, 1990. | |
| dog | LD50 | intravenous | 10mg/kg (10mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: FOOD INTAKE (ANIMAL) GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" | Food and Cosmetics Toxicology. Vol. 17, Pg. 605, 1979. |
| hamster | LD50 | intraperitoneal | 10mg/kg (10mg/kg) | Food and Cosmetics Toxicology. Vol. 18, Pg. 173, 1980. | |
| hamster | LD50 | oral | 31500ug/kg (31.5mg/kg) | Food and Cosmetics Toxicology. Vol. 18, Pg. 173, 1980. | |
| hamster | LD50 | subcutaneous | 23mg/kg (23mg/kg) | Food and Cosmetics Toxicology. Vol. 18, Pg. 173, 1980. | |
| mouse | LD50 | intracrebral | 570ug/kg (0.57mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: CYANOSIS | Toxicology. Vol. 13, Pg. 91, 1979. |
| mouse | LD50 | intraperitoneal | 5mg/kg (5mg/kg) | Acta Pharmacologica et Toxicologica. Vol. 2, Pg. 109, 1946. | |
| mouse | LD50 | intravenous | 5mg/kg (5mg/kg) | "CRC Handbook of Antibiotic Compounds," Vols.1- , Berdy, J., Boca Raton, FL, CRC Press, 1980Vol. 5, Pg. 439, 1981. | |
| mouse | LD50 | oral | 17mg/kg (17mg/kg) | LUNGS, THORAX, OR RESPIRATION: ACUTE PULMONARY EDEMA LIVER: FATTY LIVER DEGERATION KIDNEY, URETER, AND BLADDER: OTHER CHANGES | Toxicology and Applied Pharmacology. Vol. 45, Pg. 275, 1978. |
| mouse | LD50 | subcutaneous | 10mg/kg (10mg/kg) | BEHAVIORAL: EXCITEMENT LUNGS, THORAX, OR RESPIRATION: DYSPNEA LUNGS, THORAX, OR RESPIRATION: RESPIRATORY STIMULATION | Food and Cosmetics Toxicology. Vol. 18, Pg. 181, 1980. |
| mouse | LDLo | unreported | 8mg/kg (8mg/kg) | British Journal of Cancer. Vol. 15, Pg. 85, 1961. | |
| rabbit | LDLo | intravenous | 12mg/kg (12mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: PLEURAL EFFUSION | Lancet. Vol. 245, Pg. 631, 1943. |
| rat | LD50 | intraperitoneal | 4590ug/kg (4.59mg/kg) | BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY) LUNGS, THORAX, OR RESPIRATION: DYSPNEA GASTROINTESTINAL: OTHER CHANGES | Annales Recherches Veterinaires. Vol. 8, Pg. 41, 1977. |
| rat | LD50 | intravenous | 8570ug/kg (8.57mg/kg) | BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY) LUNGS, THORAX, OR RESPIRATION: DYSPNEA GASTROINTESTINAL: OTHER CHANGES | Annales Recherches Veterinaires. Vol. 8, Pg. 41, 1977. |
| rat | LD50 | oral | 27790ug/kg (27.79mg/kg) | BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY) LUNGS, THORAX, OR RESPIRATION: DYSPNEA GASTROINTESTINAL: OTHER CHANGES | Annales Recherches Veterinaires. Vol. 8, Pg. 41, 1977. |
| rat | LD50 | subcutaneous | 11mg/kg (11mg/kg) | BEHAVIORAL: FOOD INTAKE (ANIMAL) LUNGS, THORAX, OR RESPIRATION: DYSPNEA SKIN AND APPENDAGES (SKIN): HAIR: OTHER | Food and Chemical Toxicology. Vol. 20, Pg. 289, 1982. |
Consensus Reports
IARC Cancer Review: Group 3 IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 7 , 1987,p. 56.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) ; Animal Limited Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 10 , 1976,p. 205.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) ; Animal Inadequate Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 40 , 1986,p. 83.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) . EPA Genetic Toxicology Program.
Safety Profile
Poison by ingestion, subcutaneous, intracerebral, intraperitoneal, intravenous, and possibly other routes. An experimental teratogen. Other experimental reproductive effects. Human mutation data reported. Questionable carcinogen with experimental neoplastigenic and teratogenic data. An antimicrobial agent. When heated to decomposition it emits acrid smoke and irritating fumes.
Safety Information of Clavacin (CAS NO.149-29-1):
Hazard Codes: T.gif){kind=small}
,Xn.gif){kind=small}
,C.gif){kind=small}
,F.gif){kind=small}
Risk Statements: 25-38-48/20/22-40-22-34-11
11: Highly Flammable
20: Harmful by inhalation
22: Harmful if swallowed
25: Toxic if swallowed
34: Causes burns
38: Irritating to the skin
40: Limited evidence of a carcinogenic effect
48: Danger of serious damage to health by prolonged exposure
Safety Statements: 45-36/37-36/37/39-26-16
16: Keep away from sources of ignition - No smoking
26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice
36: Wear suitable protective clothing
37: Wear suitable gloves
39: Wear eye/face protection
45: In case of accident or if you feel unwell, seek medical advice immediately (show label where possible)
Specification
Clavacin ,its CAS NO. is 149-29-1,the synonyms is (2,4-Dihydroxy-2h-pyran-3(6h)-ylidene)aceticacid-3,4-lactone;2,4-dihydroxy-2h-pyran-delta-3(6h),alpha-aceticacid-3,4-lactone ; 2-C(pyran-2(6h)-one,4-hydroxy-4h-furo) ; 2H-pyran-delta(sup3(6h),alpha)-aceticacid,2,4-dihydroxy-,3,4-lactone ; Aceticacid,(2,4-dihydroxy-2h-pyran-3(6h)-ylidene)-,3,4-lactone ; Clairformin ; Patulin .
-
Premium Related Products
